Study Reveals Importance Of Timing For Cellular Signals, Suggests Possible Tactic For Cancer Therapeutics
Magic tricks work because they take advantage of the brain’s sensory assumptions, tricking audiences into seeing phantoms or overlooking sleights of hand. Now a team of UC San Francisco researchers has discovered that even brainless single-celled yeast have sensory biases that can be hacked by a carefully engineered illusion, a finding that could be used to develop new approaches to fighting diseases such as cancer.
“The ability to perceive and respond to the environment is a basic attribute of all living organisms, from the greatest to the smallest,” said Wendell Lim, PhD, the study’s senior author. “And so is the susceptibility to misperception. It doesn’t matter if the illusion is based on molecular sensors within a single cell or neurons in the brain.”
In the new study, published online Nov. 19, 2015 in Science Express, Lim and his team discovered that yeast cells falsely perceive a specifically timed pattern of stress – caused by alternating between low and mildly increased sodium levels – as a massive, continuously increasing ramp of stress. In response, the microbes end up over-responding and killing themselves. The results, Lim says, suggest a whole new way of looking at the perceptual abilities of simple cells and could even be used to develop new approaches to fighting diseases using the power of illusion.
Timing of stress response is yeast cells’ ‘Achilles heel’
“This discovery was a bit of an accident actually,” said Lim, chair of the Department of Cellular and Molecular Pharmacology at UCSF, director of the UCSF Center for Systems and Synthetic Biology, and a Howard Hughes Medical Institute (HHMI) investigator. “We were interested in the general issue of how cells interpret information over time. Frequency is a key aspect of all our communications, whether it’s hearing language or transmitting radio signals, but do cells themselves use this kind of information? It’s something we don’t know much about.”
To explore this question, two postdoctoral fellows in Lim’s lab, Ping Wei, PhD, now at Peking University School of Life Sciences, and Amir Mitchell, PhD, set up a system that allowed them to expose yeast to a mild stressor – a small increase in salt in the yeast’s environment – and to oscillate between the increased salt level and the baseline level at different frequencies.
Normally, sensor molecules in a yeast cell detect changes in salt concentration and instruct the cell to respond by producing a protective chemical. After this transient response, the cell can resume growing happily as if conditions had not changed. The researchers found that the cells were perfectly capable of adapting when they flipped the salt stress on and off every minute or every 32 minutes. But to their surprise, when they tried an eight-minute oscillation of precisely the same salt level the cells quickly stopped growing and began to die off.
“That was just a jaw-dropping moment,” said Mitchell. “These cells should be able to handle this level of osmotic stress, but at one particular frequency they just go haywire. We’d never seen anything like this before.”
Could sensory illusions be used to fight cancer?
Mitchell, who was first author on the new study, went on to inspect the cellular mechanism underlying this unexpected, frequency-dependent toxicity. Using mathematical modeling and experiments in which he tweaked the molecular wiring of the mitogen activated protein kinase (MAPK) pathway that mediates the cells’ salt-sensing system, he revealed a sensory misperception: Because of the way the MAPK pathway is set up, the cells interpret an eight-minute oscillation as an ever-increasing staircase of salt concentration. This leads to excessive activation of the cells’ protective response, and ultimately to their death (see Movie).
The Latest on: Cancer Therapeutics
via Google News
The Latest on: Cancer Therapeutics
- Unleashing the cancer-fighting gene TP53 in leukemia with a novel combination treatmenton January 19, 2021 at 5:41 am
Drugs that target the cancer-promoting proteins MDM2 and BET have been tried in acute myeloid leukemia (AML) but haven’t been all that effective on their own. In a new study, combining the two ...
- Starton Therapeutics reimagines existing medicines to fight blood cancer with continuous dosing technologyon January 19, 2021 at 5:24 am
The company develops transdermal (on the skin) and subcutaneous (under the skin) delivery treatments that administer targeted medicines ...
- Lilly to help Dutch biotech develop cancer therapies in deal worth up to $1.6Bon January 19, 2021 at 4:47 am
Merus N.V. specializes is so-called CD3 engaging T-cell therapies, a growing area of cancer research, based on immunotherapy, or using the immune system’s T cells to find and shrink tumors ...
- Lilly to Pay Merus as Much as $1.6 Billion in Cancer Team-Upon January 19, 2021 at 4:00 am
Eli Lilly & Co. will pay Merus NV as much as $1.6 billion to collaborate on research and development of up to three early experimental cancer drugs.
- The Global Cancer Gene Therapy Market is expected to grow by $ 2.96 bn during 2021-2025 progressing at a CAGR of 20% during the forecast periodon January 19, 2021 at 3:02 am
Reportlinker.com announces the release of the report "Global Cancer Gene Therapy Market 2021-2025" - Our report on cancer gene therapy market provides a holistic analysis, market size and forecast, ...
- Investors Up the Ante for Drugs Striking Cancer via DNA Repairon January 19, 2021 at 12:04 am
A colossal deal struck last month between Germany’s Merck KGaA and UK-based Artios Pharma is one of several highlighting soaring interest in cancer drugs that target the DNA repair systems of our ...
- Prescient Therapeutics chooses three cancer programs for its next-generation CAR T platformon January 18, 2021 at 9:56 pm
Australian biotech company Prescient Therapeutics (ASX:PTX) has announced what’s next for its next-generation gene therapy technology for fighting cancer.
- Colorectal Cancer Diagnostics and Therapeutics Market - Global Growth, Trends, and Forecasts to 2025on January 15, 2021 at 6:08 am
The "Colorectal Cancer Diagnostics and Therapeutics Market - Growth, Trends, and Forecasts (2020 - 2025)" report has ...
- Cytovia Therapeutics Partners with National Cancer Institute to Develop Novel Gene-Edited,on January 13, 2021 at 10:52 pm
Cytovia Therapeutics, an emerging biopharmaceutical company focusing on Natural Killer cells in cancer, announced today that it has signed a licensing agreement with the National Cancer Institute (NCI ...
- Pet Cancer Therapeutics Market 2020 Key Dynamics, Recent and Future Demand, Trend, Analysis upto 2027on January 12, 2021 at 6:03 pm
Global " Pet Cancer Therapeutics Market" 2020 report includes the market strategy, market orientation, expertise ...
via Bing News